Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5583892 | Seminars in Arthritis and Rheumatism | 2017 | 26 Pages |
Abstract
In this article, we gathered the current results on the contribution of microRNA and long non-coding RNA in rheumatoid arthritis pathogenesis and their potential use in rheumatoid arthritis treatment. Although the present stage of studies on this matter is still very early, many studies have confirmed non-coding RNAs' involvement in rheumatoid arthritis development. We showed ncRNAs changes in various tissues or cell lines of RA in humans or in animal models of RA. We tried to present possible mechanisms causing respective modifications of ncRNAs expression. There are some propositions to use some of them as markers of rheumatoid arthritis. Moreover, very advanced techniques of drug preparation are proposed to influence the microRNA or lncRNA pathways to inhibit inflammation in RA patients. None of them are now at the trial stage, but some are very promising.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Bogdan MD, PhD, Maria MD, PhD,